For instance, BCR-ABL was found to be directly involved in the regulation of DNA repair decreasing the expression of DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) in patients with chronic myeloid leukemia (CML) [3]. Here, PRKDC is linked to chronic myelogenous leukemia, BCR-ABL1 positive.